You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Group 3 PH

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension Trial in Durham (Hyperpolarized 129Xe)

Not yet recruiting
  • Interstitial Lung Disease
  • +2 more
  • Hyperpolarized 129Xe
  • Durham, North Carolina
    Duke University Medical Center
Jan 14, 2022

Pulmonary Hypertension Trial in Vienna (Aria CV Acute PH System)

Recruiting
  • Pulmonary Hypertension
  • Aria CV Acute PH System
  • Vienna, Austria
    Medical University of Vienna
Mar 14, 2022

Bullous Pemphigoid Trial in Worldwide (biological, other, drug)

Recruiting
  • Bullous Pemphigoid
  • efgartigimod PH20 SC
  • +2 more
  • Fountain Valley, California
  • +24 more
Jul 27, 2022

Overactive Bladder (OAB), Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron, Placebo)

Recruiting
  • Overactive Bladder (OAB)
  • Pharmacokinetics of Mirabegron
  • Edegem, Belgium
  • +34 more
Nov 28, 2022

Ph+ ALL Trial in China (Olverembatinib, Imatinib)

Recruiting
  • Ph+ ALL
  • Chongqing, Chongqing, China
  • +8 more
Sep 22, 2023

Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via

Completed
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled NO delivered via INOpulse DS-C Device
  • Placebo delivered via INOpulse DS-C Device
  • Jasper, Alabama
  • +42 more
Jul 13, 2022

In Vitro Fertilisation Outcome Trial in Egypt (Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6, Transfer embryo

Active, not recruiting
  • In Vitro Fertilisation Outcome
  • Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6
  • +2 more
  • Assiut, Egypt
  • +5 more
Aug 13, 2022

Phosphorus Metabolism Disorders, Acid-Base Balance Disorder Trial in Warsaw (Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35

Completed
  • Phosphorus Metabolism Disorders
  • Acid-Base Balance Disorder
  • Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35 mmol/L
  • Group 2: C) Dbic 30 -35 mmol/L B) Dbic 35- 30 mmol/L
  • Warsaw, Poland
    Wieliczko Monika
May 21, 2023

Group 2 Pulmonary Hypertension, Heart Failure Trial (Gradient Denervation System)

Not yet recruiting
  • Group 2 Pulmonary Hypertension
  • Heart Failure
  • Gradient Denervation System
  • (no location specified)
Sep 18, 2023

Hypertension, Pulmonary Trial in Germany, United Kingdom (Blood Sample, Cardiac MRI)

Completed
  • Hypertension, Pulmonary
  • Blood Sample
  • Cardiac MRI
  • Bonn, Germany
  • +7 more
Aug 16, 2022

GERD Trial in Ljubljana (Linaprazan Glurate 25 mg, Linaprazan Glurate 50 mg, Linaprazan Glurate 75 mg)

Recruiting
  • GERD
  • Linaprazan Glurate 25 mg
  • +2 more
  • Ljubljana, Slovenia
    CRS d.o.o,Ukmarjeva ulica 6
Feb 23, 2023

Vaginal Flora Imbalance Trial in Osasco (Stryphnodendron Adstringens 3% - once daily post bath)

Not yet recruiting
  • Vaginal Flora Imbalance
  • Stryphnodendron Adstringens 3% - once daily post bath
  • Osasco, São Paulo, Brazil
    Medcin Instituto da Pele
Oct 10, 2023

Pulmonary Hypertension Trial (TNX-103, Placebo)

Not yet recruiting
  • Pulmonary Hypertension
  • (no location specified)
Aug 1, 2023

Type 2 Diabetes Trial (behavioral, device, other)

Not yet recruiting
  • Type 2 Diabetes
  • Acceptance and Commitment Therapy
  • +2 more
  • (no location specified)
Sep 5, 2023

Heart Failure, Pulmonary Hypertension Trial in Vancouver, Ottawa (Rivet Shunt)

Not yet recruiting
  • Heart Failure
  • Pulmonary Hypertension
  • Rivet Shunt
  • Vancouver, British Columbia, Canada
  • +1 more
Sep 26, 2022

Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

Not yet recruiting
  • Bullous Pemphigoid
  • (no location specified)
Dec 27, 2022

Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

Recruiting
  • Bioequivalence
  • efgartigimod PH20 SC as a prefilled syringe presentation
  • efgartigimod PH20 SC as a vial + syringe presentation
  • Tempe, Arizona
  • +1 more
Apr 5, 2023

Myositis Trial (EFG PH20 SC)

Not yet recruiting
  • Myositis
  • EFG PH20 SC
  • (no location specified)
Jul 28, 2023

Stroke, Acute Trial in London (3D CEST imaging)

Recruiting
  • Stroke, Acute
  • 3D CEST imaging
  • London, United Kingdom
    King's College Hospital
Apr 4, 2022

PAH, Pulmonary Hypertension, Hypertension Trial in Worldwide (Ralinepag, Placebo)

Recruiting
  • PAH
  • +10 more
  • Tucson, Arizona
  • +36 more
Jan 27, 2023

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Anastomotic Leak Trial in Canada, Saudi Arabia, United States (NERv's Inline Device)

Recruiting
  • Anastomotic Leak
  • NERv's Inline Device
  • Cleveland, Ohio
  • +5 more
Jan 20, 2023

Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)

Not yet recruiting
  • Group 3 Pulmonary Hypertension
  • recombinant human brain natriuretic peptide
  • Placebo
  • (no location specified)
Jan 30, 2023

Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)

Terminated
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled treprostinil solution
  • Placebo solution
  • Birmingham, Alabama
  • +75 more
Jan 5, 2023

Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Heidelberg (exercise and respiratory therapy,

Recruiting
  • Pulmonary Hypertension
  • Chronic Thromboembolic Pulmonary Hypertension
  • exercise and respiratory therapy
  • sedentary control group
  • Heidelberg, Baden-Wuerttemberg, Germany
    Thoraxclinic at the University Hospital Heidelberg
Jul 12, 2022